These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6259398)
1. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies. Biggar RJ; Nkrumah FK; Henle W; Levine PH J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398 [TBL] [Abstract][Full Text] [Related]
2. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma. Neequaye J; Viza D; Pizza G; Levine PH; De Vinci C; Ablashi DV; Biggar RJ; Nkrumah FK Anticancer Res; 1990; 10(5A):1183-7. PubMed ID: 2173470 [TBL] [Abstract][Full Text] [Related]
3. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma. Judson SC; Henle W; Henle G N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197 [TBL] [Abstract][Full Text] [Related]
4. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
5. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens. Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787 [TBL] [Abstract][Full Text] [Related]
6. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients. Morrow RH; Sever JL; Henderson BE Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991 [No Abstract] [Full Text] [Related]
7. Transfer factor in prevention of Burkitt's lymphoma relapses. Nkrumah FK; Pizza G; Neequaye J; Viza D; De Vinci C; Levine PH J Exp Pathol; 1987; 3(4):463-9. PubMed ID: 2842479 [TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus. Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related]
10. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment. Gunvén P Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070 [No Abstract] [Full Text] [Related]
11. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA). Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866 [TBL] [Abstract][Full Text] [Related]
12. Burkitt's lymphoma in Thai children: an analysis of 25 cases. Suvatte V; Mahasandana C; Tanphaichitr VS; Tuchinda S; Parichatikanond P; Pacharee P Southeast Asian J Trop Med Public Health; 1983 Sep; 14(3):385-93. PubMed ID: 6318366 [TBL] [Abstract][Full Text] [Related]
13. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma. Gunvén P; Klein G; Clifford P; Singh S Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538 [TBL] [Abstract][Full Text] [Related]
15. Japanese Burkitt's lymphoma: clinicopathological review of 14 cases. Miyoshi I Jpn J Clin Oncol; 1983 Sep; 13(3):489-96. PubMed ID: 6315992 [TBL] [Abstract][Full Text] [Related]
16. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases]. Gunven P G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758 [No Abstract] [Full Text] [Related]
17. Epstein-Barr virus-associated Burkitt's lymphoma in India. Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592 [TBL] [Abstract][Full Text] [Related]
18. A case of malignant lymphoma, undifferentiated, Burkitt's type with high antibodies to Epstein-Barr virus. Chen W; Yang KC; Shih JS; Hsu CA; Yeh YS; Chen TY Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Sep; 13(3):343-9. PubMed ID: 6265160 [TBL] [Abstract][Full Text] [Related]
19. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma. Hesseling PB; Molyneux E; Kamiza S; Broadhead R Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]